{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:22:14Z","timestamp":1761488534434},"reference-count":14,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.vaccine.2010.08.062","type":"journal-article","created":{"date-parts":[[2010,8,27]],"date-time":"2010-08-27T05:53:33Z","timestamp":1282888413000},"page":"7215-7220","source":"Crossref","is-referenced-by-count":31,"title":["Post-licensure comparison of the safety profile of diphtheria\/tetanus\/whole cell pertussis\/haemophilus influenza type b vaccine and a 5-in-1 diphtheria\/tetanus\/acellular pertussis\/haemophilus influenza type b\/polio vaccine in the United Kingdom"],"prefix":"10.1016","volume":"28","author":[{"given":"Nick","family":"Andrews","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Stowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley","family":"Wise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.08.062_bib0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/adc.2005.076109","article-title":"Evaluation of a diphtheria\u2013tetanus\u2013acellular pertussis-inactivated poliovirus\u2013Haemophilus influenzae type b vaccine given concurrently with meningococcal group C conjugate vaccine at 2, 3 and 4 months of age","volume":"92","author":"Kitchin","year":"2007","journal-title":"Arch Dis Child"},{"issue":"9368","key":"10.1016\/j.vaccine.2010.08.062_bib0010","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(03)13171-6","article-title":"Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis","volume":"361","author":"McVernon","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2010.08.062_bib0015","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1086\/314901","article-title":"The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination","volume":"180","author":"Goldblatt","year":"1999","journal-title":"J Infect Dis"},{"issue":"9091","key":"10.1016\/j.vaccine.2010.08.062_bib0020","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)06508-2","article-title":"Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines","volume":"350","author":"Olin","year":"1997","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.vaccine.2010.08.062_bib0025","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1016\/j.vaccine.2006.02.018","volume":"24","author":"Kitchin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.08.062_bib0030","unstructured":"General Practice Research Database. http:\/\/www.gprd.com\/home\/default.asp [accessed 09.08.10]."},{"issue":"11","key":"10.1016\/j.vaccine.2010.08.062_bib0035","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/oxfordjournals.aje.a008695","article-title":"Case series analysis of adverse reactions to vaccines: a comparative evaluation","volume":"143","author":"Farrington","year":"1996","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2010.08.062_bib0040","series-title":"Stata Statistical Software: Release 8","author":"Stata reference StataCorp.","year":"2003"},{"issue":"8949","key":"10.1016\/j.vaccine.2010.08.062_bib0045","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0140-6736(95)90471-9","article-title":"A new method for active surveillance of adverse events from diphtheria\/tetanus\/pertussis and measles\/mumps rubella vaccine","volume":"345","author":"Farrington","year":"1995","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2010.08.062_bib0050","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1542\/peds.112.5.e348","article-title":"Decrease in hospital admissions for febrile seizures and reports of hypotonic\u2013hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: a report from IMPACT","volume":"112","author":"Le Saux","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2010.08.062_bib0055","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/01.ede.0000155506.05636.a4","article-title":"Active surveillance of vaccine safety: a system to detect early signs of adverse events","volume":"16","author":"Davis","year":"2005","journal-title":"Epidemiology"},{"issue":"4","key":"10.1016\/j.vaccine.2010.08.062_bib0060","doi-asserted-by":"crossref","first-page":"E52","DOI":"10.1542\/peds.106.4.e52","article-title":"Hypotonic\u2013hyporesponsive episodes reported to the Vaccine Adverse Event Reporting System (VAERS), 1996\u20131998","volume":"106","author":"DuVernoy","year":"2000","journal-title":"Pediatrics"},{"issue":"9091","key":"10.1016\/j.vaccine.2010.08.062_bib0065","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)06508-2","article-title":"Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines","volume":"350","author":"Olin","year":"1997","journal-title":"Lancet"},{"issue":"9698","key":"10.1016\/j.vaccine.2010.08.062_bib0070","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(09)61208-3","article-title":"Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials","volume":"374","author":"Prymula","year":"2009","journal-title":"Lancet"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10012193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10012193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T05:59:52Z","timestamp":1559455192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10012193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":14,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0264410X10012193"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.08.062","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}